Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

2.

Novel ADC Improves Survival in Metastatic TNBC

3.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

4.

Three out of ten breast cancers detected between screenings, study finds

5.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot